Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
John R. Teerlink, Adriaan A. Voors, Piotr Ponikowski, et al.
European Journal of Heart Failure (2017) Vol. 19, Iss. 6, pp. 800-809
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
Petar Seferović, Mark C. Petrie, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 5, pp. 853-872
Open Access | Times Cited: 591
Heart failure
Marco Metra, John R. Teerlink
The Lancet (2017) Vol. 390, Iss. 10106, pp. 1981-1995
Closed Access | Times Cited: 562
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
J. Atherton, Andrew Sindone, Carmine G. De Pasquale, et al.
Heart Lung and Circulation (2018) Vol. 27, Iss. 10, pp. 1123-1208
Open Access | Times Cited: 361
Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey
Nicolas Girerd, Marie‐France Seronde, Stefano Coiro, et al.
JACC Heart Failure (2017) Vol. 6, Iss. 4, pp. 273-285
Closed Access | Times Cited: 228
Effects of Serelaxin in Patients with Acute Heart Failure
Marco Metra, John R. Teerlink, Gad Cotter, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 8, pp. 716-726
Open Access | Times Cited: 226
Highlights in heart failure
Daniela Tomasoni, Marianna Adamo, Carlo Lombardi, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 6, pp. 1105-1127
Open Access | Times Cited: 212
Small animal models of heart failure
Christian Riehle, Johann Bauersachs
Cardiovascular Research (2019) Vol. 115, Iss. 13, pp. 1838-1849
Open Access | Times Cited: 189
Peripartum cardiomyopathy
Michael C. Honigberg, Michael M. Givertz
BMJ (2019), pp. k5287-k5287
Open Access | Times Cited: 141
Neutrophil-Lymphocyte Ratio in Patients with Acute Heart Failure Predicts In-Hospital and Long-Term Mortality
Jun Hwan Cho, Hyun‐Jai Cho, Hae‐Young Lee, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 557-557
Open Access | Times Cited: 99
Heart failure and sepsis: practical recommendations for the optimal management
Angelos Arfaras-Melainis, Effie Polyzogopoulou, Filippos Triposkiadis, et al.
Heart Failure Reviews (2019) Vol. 25, Iss. 2, pp. 183-194
Closed Access | Times Cited: 63
Worsening renal function in acute heart failure in the context of diuretic response
Johanna E. Emmens, Jozine M. ter Maaten, Yuya Matsue, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 2, pp. 365-374
Open Access | Times Cited: 52
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
Bart J van Essen, Jasper Tromp, Jozine M. ter Maaten, et al.
European Journal of Heart Failure (2022) Vol. 25, Iss. 1, pp. 35-42
Open Access | Times Cited: 34
The difference in referencing in Web of Science, Scopus, and Google Scholar
Markus S. Anker, Sara Hadzibegovic, Alessia Lena, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 6, pp. 1291-1312
Open Access | Times Cited: 52
Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
Simona Silvetti, Alessandro Belletti, Antonella Fontana, et al.
ESC Heart Failure (2017) Vol. 4, Iss. 4, pp. 595-604
Open Access | Times Cited: 51
Clinical profiles in acute heart failure: an urgent need for a new approach
B. L. Chapman, Adam D. DeVore, Robert J. Mentz, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 3, pp. 464-474
Open Access | Times Cited: 50
Immune regulation of cardiac fibrosis post myocardial infarction
Yusra Zaidi, Eslie G. Aguilar, Miguel Troncoso, et al.
Cellular Signalling (2020) Vol. 77, pp. 109837-109837
Open Access | Times Cited: 49
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
Tim Wilhelmi, Xingbo Xu, Xiao-Ying Tan, et al.
Theranostics (2020) Vol. 10, Iss. 9, pp. 3905-3924
Open Access | Times Cited: 46
Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis
William A. Blessing, Stephen Okajima, M. Belén Cubria, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 25, pp. 12183-12192
Open Access | Times Cited: 44
AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
Bryna S.M. Chow, Martina Kočan, Matthew Shen, et al.
Journal of the American Society of Nephrology (2019) Vol. 30, Iss. 11, pp. 2191-2207
Open Access | Times Cited: 43
Another One Fights the Dust: Targeting the NLRP3 Inflammasome for the Treatment of Silicosis
Maggie Lam, Ashley Mansell, Michelle D. Tate
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 66, Iss. 6, pp. 601-611
Closed Access | Times Cited: 24
<p>New therapies for the treatment of heart failure: a summary of recent accomplishments</p>
Filip Machaj, Elżbieta Dembowska, Jakub Rosik, et al.
Therapeutics and Clinical Risk Management (2019) Vol. Volume 15, pp. 147-155
Open Access | Times Cited: 38
Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics
Sanjana Gupta, Ruth J. Pepper, Neil Ashman, et al.
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 37
Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts
Beth A. Gabris-Weber, Rameen Forghani, Thomas Dschietzig, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116136-116136
Closed Access | Times Cited: 4
Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management
Wang Dui, Zhao Xiao-bin, Zhang Haifeng, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Lessons learned in acute heart failure
Baljash Cheema, Andrew P. Ambrosy, Rachel M. Kaplan, et al.
European Journal of Heart Failure (2017) Vol. 20, Iss. 4, pp. 630-641
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top